Related references
Note: Only part of the references are listed.Comprehensive immunotherapy combined with intratumoral injection of zoledronate-pulsed dendritic cells, intravenous adoptive activated T lymphocyte and gemcitabine in unresectable locally advanced pancreatic carcinoma: a phase I/II trial
Yoshiki Hirooka et al.
ONCOTARGET (2018)
Antitumor Efficacy of Human Monocyte-Derived Dendritic Cells: Comparing Effects of two Monocyte Isolation Methods
Graca S. Marques et al.
BIOLOGICAL PROCEDURES ONLINE (2018)
Tumor infiltrating lymphocytes in early breast cancer
Giancarlo Pruneri et al.
BREAST (2018)
CD137L dendritic cells induce potent response against cancer-associated viruses and polarize human CD8+ T cells to Tc1 phenotype
Bhushan Dharmadhikari et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Activation of p53 in Immature Myeloid Precursor Cells Controls Differentiation into Ly6c+CD103+ Monocytic Antigen-Presenting Cells in Tumors
Madhav D. Sharma et al.
IMMUNITY (2018)
Immunogenic Apoptosis as a Novel Tool for Anticancer Vaccine Development
Barbara Montico et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Immune Infiltration in Invasive Lobular Breast Cancer
Christine Desmedt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents
Natasa Obermajer et al.
NATURE PROTOCOLS (2018)
High immune cell score predicts improved survival in pancreatic cancer
Kyosti Tahkola et al.
VIRCHOWS ARCHIV (2018)
Distinctive profiles of tumor-infiltrating immune cells and association with intensity of infiltration in colorectal cancer
Yugang Wu et al.
ONCOLOGY LETTERS (2018)
Immune Infiltration in Invasive Lobular Breast Cancer
Christine Desmedt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Quantitative Analysis of Immune Infiltrates in Primary Melanoma
Robyn D. Gartrell et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human
Joachim G. J. V. Aerts et al.
CLINICAL CANCER RESEARCH (2018)
Efficacy of intracellular immune checkpoint-silenced DC vaccine
Danhong Wang et al.
JCI INSIGHT (2018)
Efficient Presentation of Soluble Antigen by Cultured Human Dendritic Cells Is Maintained by Granulocyte/Macrophage Colony-stimulating Factor Plus Interleukin 4 and Downregulated by Tumor Necrosis Factor α
Federica Sallusto et al.
JOURNAL OF IMMUNOLOGY (2018)
Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer
Jitka Fucikova et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2pos DCIS Independent of Route: Results of Randomized Selection Design Trial
Lea Lowenfeld et al.
CLINICAL CANCER RESEARCH (2017)
High-Dimensional Phenotypic Mapping of Human Dendritic Cells Reveals Interindividual Variation and Tissue Specialization
Marcela Alcantara-Hernandez et al.
IMMUNITY (2017)
Dendritic cell-based immunotherapy: a basic review and recent advances
Joao Constantino et al.
IMMUNOLOGIC RESEARCH (2017)
A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
Susana Inoges et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
Irradiation enhances dendritic cell potential antitumor activity by inducing tumor cell expressing TNF-α
Lijia Chang et al.
MEDICAL ONCOLOGY (2017)
Mapping the human DC lineage through the integration of high-dimensional techniques
Peter See et al.
SCIENCE (2017)
Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape
Abhishek D. Garg et al.
TRENDS IN IMMUNOLOGY (2017)
Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model
Manh-Cuong Vo et al.
ONCOTARGET (2017)
Characterization of Interleukin-15-Transpresenting Dendritic Cells for Clinical Use
J. M. J. Van den Bergh et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
Intratumoral Lentivector-Mediated TGF-β1 Gene Downregulation As a Potent Strategy for Enhancing the Antitumor Effect of Therapy Composed of Cyclophosphamide and Dendritic Cells
Joanna Rossowska et al.
FRONTIERS IN IMMUNOLOGY (2017)
Adjuvant immunotherapy with autologous dendritic cells for hepatocellular carcinoma, randomized phase II study
Jeong-Hoon Lee et al.
ONCOIMMUNOLOGY (2017)
Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy
Nada Hradilova et al.
PLOS ONE (2017)
Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC
Chunlei Ge et al.
BMC CANCER (2017)
Exhaustion of T lymphocytes in the tumor microenvironment: Significance and effective mechanisms
Mohammad Davoodzadeh Gholami et al.
CELLULAR IMMUNOLOGY (2017)
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
Sebastien Anguille et al.
BLOOD (2017)
Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration
Jay M. Lee et al.
CLINICAL CANCER RESEARCH (2017)
Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients
Stefanie Gross et al.
JCI INSIGHT (2017)
Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells
Gerty Schreibelt et al.
CLINICAL CANCER RESEARCH (2016)
Monocyte-Derived Dendritic Cells Promote Th Polarization, whereas Conventional Dendritic Cells Promote Th Proliferation
Kevin V. Chow et al.
JOURNAL OF IMMUNOLOGY (2016)
Dendritic Cell-Based Immunotherapy: State of the Art and Beyond
Kalijn F. Bol et al.
CLINICAL CANCER RESEARCH (2016)
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
Helene Salmon et al.
IMMUNITY (2016)
The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity
Damya Laoui et al.
NATURE COMMUNICATIONS (2016)
A Phase I Clinical Trial of CD1c (BDCA-1)+ Dendritic Cells Pulsed With HLA-A*0201 Peptides for Immunotherapy of Metastatic Hormone Refractory Prostate Cancer
Rebecca L. Prue et al.
JOURNAL OF IMMUNOTHERAPY (2015)
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
Duane A. Mitchell et al.
NATURE (2015)
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger et al.
NATURE (2015)
Monocyte-Derived Dendritic cells are essential for cD8+ T cell activation and antitumor responses after local immunotherapy
Sabine Kuhn et al.
FRONTIERS IN IMMUNOLOGY (2015)
Type I interferons in anticancer immunity
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
Miranda L. Broz et al.
CANCER CELL (2014)
Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205
Madhav V. Dhodapkar et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
The effects of zoledronate on monocyte-derived dendritic cells from melanoma patients differ depending on the clinical stage of the disease
Alessandra Failli et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny
Martin Guilliams et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients
Jurjen Tel et al.
CANCER RESEARCH (2013)
Control of T Helper 2 Responses by Transcription Factor IRF4-Dependent Dendritic Cells
Yan Gao et al.
IMMUNITY (2013)
IRF4 Transcription Factor- Dependent CD11b+ Dendritic Cells in Human and Mouse Control Mucosal IL-17 Cytokine Responses
Andreas Schlitzer et al.
IMMUNITY (2013)
Targeting immunosuppression for cancer therapy
Cristina Ghirelli et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Origin of monocytes and macrophages in a committed progenitor
Jan Hettinger et al.
NATURE IMMUNOLOGY (2013)
Decisions About Dendritic Cells: Past, Present, and Future
Ralph M. Steinman
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
The equivalents of human blood and spleen dendritic cell subtypes can be generated in vitro from human CD34+ stem cells in the presence of fms-like tyrosine kinase 3 ligand and thrombopoietin
A. I. Proietto et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2012)
Complex evaluation of human monocyte-derived dendritic cells for cancer immunotherapy
Katerina Vopenkova et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Tumor associated regulatory dendritic cells
Yang Ma et al.
SEMINARS IN CANCER BIOLOGY (2012)
The determinants of tumour immunogenicity
Thomas Blankenstein et al.
NATURE REVIEWS CANCER (2012)
Zoledronic acid modulates maturation of human monocyte-derived dendritic cells
Giulia Orsini et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Targeted antigen delivery and activation of dendritic cells in vivo: Steps towards cost effective vaccines
Paul J. Tacken et al.
SEMINARS IN IMMUNOLOGY (2011)
Consolidative Dendritic Cell-based Immunotherapy Elicits Cytotoxicity against Malignant Mesothelioma
Joost P. Hegmans et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity
Sebastian Kreiter et al.
CANCER RESEARCH (2010)
CD137 ligand signaling induces human monocyte to dendritic cell differentiation
Shaqireen M. M. Kwajah et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
From skin dendritic cells to a simplified classification of human and mouse dendritic cell subsets
Martin Guilliams et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Immune infiltration in human tumors: a prognostic factor that should not be ignored
F. Pages et al.
ONCOGENE (2010)
Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients
Pauline Verdijk et al.
CLINICAL CANCER RESEARCH (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Dendritic cell subsets in primary and secondary T cell responses at body surfaces
William R. Heath et al.
NATURE IMMUNOLOGY (2009)
Copulsing tumor antigen-pulsed dendritic cells with zoledronate efficiently enhance the expansion of tumor antigen-specific CD8+ T cells via Vγ9γδ T cell activation
Masashi Takahara et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells
Naofumi Shinagawa et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo
Shalin H. Naik et al.
NATURE IMMUNOLOGY (2007)
Dendritic-cell immunotherapy:: from ex vivo loading to in vivo targeting
Paul J. Tacken et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Dendritic cells for active immunotherapy: Optimizing design and manufacture in order to develop commercially and clinically viable products
C. A. Nicolette et al.
VACCINE (2007)
Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody
PJ Tacken et al.
BLOOD (2005)
Immunosuppressive networks in the tumour environment and their therapeutic relevance
WP Zou
NATURE REVIEWS CANCER (2005)
Dendritic cells as therapeutic vaccines against cancer
J Banchereau et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells
E Elkord et al.
IMMUNOLOGY (2005)
Chemokine gene modification of human dendritic cell-based tumor vaccines using a recombinant adenoviral vector
A Terando et al.
CANCER GENE THERAPY (2004)
Targeting dendritic cells with antigen-containing liposomes: antitumour immunity
JG Altin et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2004)
Manipulating dendritic cell biology for the active immunotherapy of cancer
DW O'Neill et al.
BLOOD (2004)
The instructive role of dendritic cells on T-cell responses
Federica Sallusto et al.
ARTHRITIS RESEARCH & THERAPY (2002)
Dendritic cells: Specialized and regulated antigen processing machines
I Mellman et al.
CELL (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
